Taxus Cardium Therapeutics

11750 Sorrento Valley Rd, Suite 250
San Diego, CA 92121 USA
Click for website

Research Sector Biotechnology; Pharmaceutical

Summary Description Therapeutic products and technologies for wound healing and cardiovascular diseases

Management Christopher J. Reinhard, Chairman of the Board, CEO, President and Treasurer; Tyler M. Dylan, Ph.D., J.D., Director, Chief Business Officer, General Counsel, Executive Vice President and Secretary; Dennis M. Mulroy, CPA - CFO; Gabor M. Rubanyi, M.D., Ph.D., Chief Scientific Officer; Robert L. Engler, M.D., Chief Medical Advisor; Mark McCutchen, Vice President, Business Development; Ted Williams, Vice President, Manufacturing and Technical Operations; Lois A. Chandler, Vice President, Biologics Development

Click here for Financial Data
Keywords: tissue repair, coronary artery disease, angioplasty, cardiovascular, nutraceuticals, metabolics, aesthetics, wound care, gene therapy


Updated: Oct. 22, 2015


Cardium Therapeutics acquires and strategically develops innovative commercial endeavors within the world of biomedicine; specifically, the Company focuses on such endeavors that have the potential to......view more

Products / Services

Lead commercial product Excellagen topical gel for advanced wound care management, has recently received FDA clearance for marketing and sale in the United States. Cardium's lead clinical development ......view more

Technology / Differentiation

Cardium's current medical opportunities portfolio, focused on health sciences and regenerative medicine, includes the Tissue Repair Company, Cardium Biologics, and the Company's in-house MedPodium Hea...view more


Cardium's current investment portfolio includes the Tissue Repair Company, Cardium Biologics, and its in-house MedPodium healthy lifestyle brand platform. The Company's lead product candidates include...view more